Whitehawk Therapeutics, Inc. (WHWK) Tops Q4 EPS by 35c
Tweet
Share
E-mailGet Alerts WHWK Hot Sheet
Join SI Premium – FREE
Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q4 EPS of ($0.34), $0.35 better than the analyst estimate of ($0.69).
For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aggreko files for proposed IPO
- Oura said to be seeking up to $3 billion in IPO
- SATO Technologies settles senior secured debt, launches C$1.5M placement
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
